Abbott CGM Systems: Complete Product Lineup

Abbott Laboratories manufactures the FreeStyle Libre family of continuous glucose monitors, the best-selling CGM line worldwide with over 6 million users across 60+ countries. Abbott pioneered the affordable flash glucose monitoring category with the original Libre sensor in 2017 and has since expanded into real-time CGM and over-the-counter biosensors.

Abbott's FreeStyle Libre family is the best-selling CGM product line globally, with over 6 million active users across more than 60 countries. In the US market, Abbott offers 4 glucose monitoring products: the prescription FreeStyle Libre 3 Plus and FreeStyle Libre 2, plus the over-the-counter Lingo and Libre Rio biosensors. The Libre 3 Plus holds the distinction of having the lowest MARD (7.9%) of any consumer CGM, making it the most accurate continuous glucose monitor available. Abbott has consistently positioned its products as the most affordable CGM option, with insured costs as low as $15 per month.

Abbott Laboratories (NYSE: ABT), founded in 1888 in Chicago, Illinois, is a diversified healthcare conglomerate with $42 billion in annual revenue. The diabetes care division generating FreeStyle Libre revenue represents one of Abbott's fastest-growing business segments, with Libre sales exceeding $5.3 billion in 2024. Abbott's dual strategy of maintaining the lowest-cost prescription CGM while simultaneously launching OTC products positions the company to capture both the medical and consumer wellness markets.